SKL-2841

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSKL-2841
Drug Alias NameSKL-2841
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane cofactor protein inhibitorsC-C motif chemokine 4 inhibitors
TargetsMembrane cofactor proteinC-C motif chemokine 4
Therapy Area/IndicationsScleroderma, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyoto Prefectural University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyoto Prefectural University
Active IndicationsN/A
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeN/A
Related LinksN/A